Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?-Reference-Cited by-同舟云学术

Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?

Published:2019-11-26 Issue:12 Volume:33 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Schinstock Carrie A.¹²^ORCID,Smith Byron H.³^ORCID,Montgomery Robert A.⁴,Jordan Stanley C.⁵,Bentall Andrew J.¹²,Mai Martin⁶,Khamash Hasan A.⁷,Stegall Mark D.²⁸^ORCID

Affiliation:

1. Division of Nephrology and Hypertension Department of Internal Medicine Mayo Clinic Rochester MN USA

2. The William J von Liebig Center for Transplantation and Clinical Regeneration Mayo Clinic Rochester MN USA

3. Department of Health Sciences Research Mayo Clinic Rochester MN USA

4. New York University Langone Transplant Institute New York NY USA

5. Cedars Sinai Medical Center Los Angeles CA USA

6. Transplant Center Mayo Clinic Jacksonville FL USA

7. Division of Nephrology and Hypertension Department of Internal Medicine Mayo Clinic Phoenix AZ USA

8. Division of Transplantation Surgery Department of Medicine Mayo Clinic Rochester MN USA

Funder

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.13751

Reference32 articles.

1. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients

2. Transplanting patients with a positive donor-specific crossmatch: A single center's perspective

3. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation

4. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1

5. Use of high‐dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars‐Sinai experience;Jordan SC;Clin Transpl,2003

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series;Transplantation Direct;2024-08-29

2. Highly Sensitized Candidates Remain at Risk for Microvascular Inflammation Even When Donor-specific Antibody Is Avoided: A Matched Cohort Study;Transplantation;2024-08-20

3. Outcomes of Kidney Transplantation in Highly HLA-Sensitized Patients Treated with Intravenous Immuno-Globulin, Plasmapheresis and Rituximab: A Meta-Analysis;Life;2024-08-10

4. Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidates;American Journal of Transplantation;2024-08

5. New Therapies for Highly Sensitized Patients on the Waiting List;Kidney360;2024-07-12